Previous 10 | Next 10 |
RealNetworks (RNWK) -12% on Q3 earnings release.Aptevo Therapeutics (APVO) -12%.vTv Therapeutics (VTVT) -8% on reporting baseline characteristics for the enrolled subjects in the ongoing Elevage clinical study of azeliragon as a potential treatment for mild Alzhe...
Gainers: Alaska Communications Systems (ALSK) +58%.Beasley Broadcast (BBGI) +39%.JAKKS Pacific (JAKK) +29%.BioLineRx (BLRX) +27%.Gannett Co (GCI) +25%.Inspire Medical Systems (INSP) +24%.GW Pharmaceuticals (GWPH) +20%.Collectors Universe (CLCT) +20%.Telenav (TNAV) +20%.Aptevo Therap...
Gainers: Inspire Medical Systems (INSP) +24%, GW Pharmaceuticals (GWPH) +15%, Aptevo Therapeutics (APVO) +14%, Galera Therapeutics (GRTX) +11%, DBV Technologies (DBVT) +10%.Losers: Esperion Therapeutics (ESPR) -15%, Aurinia Pharmaceuticals (AUPH)...
First Complete Remission Observed in a Patient in Cohort 6 Dosing Continues in Cohort 7 SEATTLE, WA / ACCESSWIRE / November 3, 2020 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immuno-oncology therapeutics based on i...
Trial Advancing on Schedule and Second Patient Dosed in Cohort 7 No Evidence of Drug-Induced Anti-Drug Antibodies Observed to Date SEATTLE, WA / ACCESSWIRE / September 1, 2020 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a biotechnology company focused on developing novel immuno-onc...
Aptevo Therapeutics (NASDAQ: APVO ) : Q2 GAAP EPS of -$2.10 beats by $0.02 . More news on: Aptevo Therapeutics Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Advances Phase 1/1b Clinical Trial of APVO436 for the Treatment of Acute Myeloid Leukemia and High-Grade Myelodysplastic Syndrome; Cohort 6 Enrollment Complete Presents New Preclinical Data Showing That ALG.APV-527 has Potential for a Favorable Safety Profile Extends Cash ...
Extends Cash Runway into Q3 2021 The Current Cash Balance is Anticipated to Create a Sufficient Timeline to Complete the APVO 436 Phase I(a) Dosing Cohorts Which Pre-Clinical Modelling Predicts May Deliver an Efficacious Dose SEATTLE, WA / ACCESSWIRE / August 6, 2020 / Aptevo Thera...
Aptevo Therapeutics ( APVO +1.9% ) has engaged Piper Sandler to sell its RUXIENCE and IXINITY royalty streams and milestone payments. More news on: Aptevo Therapeutics Inc., Healthcare stocks news, Read more ...
SEATTLE, WA / ACCESSWIRE / July 21, 2020 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a biotechnology company focused on developing novel immuno-oncology therapeutics based on its proprietary ADAPTIR™ bispecific technology platform, has engaged Piper Sandler to sell its RUXIENCE ® ...
News, Short Squeeze, Breakout and More Instantly...
Aptevo Therapeutics Inc. Company Name:
APVO Stock Symbol:
NASDAQ Market:
Aptevo Therapeutics Inc. Website:
A look at the top 10 most actives in the United States Onconetix Inc. (ONCO) rose 113.3% to $0.3178 on volume of 162,323,665 shares NVIDIA Corporation (NVDA) rose 0.8% to $118.92 on volume of 44,858,282 shares Maxeon Solar Technologies Ltd. (MAXN) rose 8.5% to $0.2648 on volume of 43,008,...
2024-07-18 06:16:00 ET 3 Tips for Using RSI When Investing in Penny Stocks Relative Strength Index (RSI) is a powerful tool for evaluating the momentum of stocks, and it can be particularly effective when investing in penny stocks . Penny stocks offer unique opportunities due to the...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 6.6% to $117.99 on volume of 383,510,118 shares Aptevo Therapeutics Inc. (APVO) rose 73.4% to $0.581 on volume of 315,289,581 shares PROSHARES TRUST (SQQQ) rose 8.7% to $8.11 on volume of 173,682,364 sha...